From tariffs and onshoring to MFN, the US has seen significant policy developments - but how will these impact pharma in 2026?

With the latest batch’s agreements, only three out of the 17 drugmakers initially targeted by Trump have not signed pricing ...

AI-driven decision engines and intelligent orchestration layers are crucial for navigating geopolitical risks and ...

Ultimately, these advancements suggest a more integrated ecosystem. Trusted regulatory spaces function like a communal ...

The worlds of technology and entrepreneurship are captivated by recent advances in generative AI and large language models (LLMs). But if the future has arrived, as science fiction writer William ...

Five years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis, or obesity — their physician will ...

The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support. For too long, specialty ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

Eli Lilly’s market capitalisation hit the $1tn mark in the past week, becoming the first healthcare company in the world to join the exclusive club dominated by technology companies. Buoyed by ...

In today’s digitally transformed world, technology plays a critical role in how pharmaceutical companies do business. From drug discovery to manufacturing and commercialization, technology is powering ...

NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited has recently signed a cooperation agreement with a leading technology-driven e-commerce platform serving ...

Based on research and analysis of the global microecology market, as well as the evaluation of relevant companies in the ...